BSE trading approval for restructured shares after NCLT insolvency plan

BSE has approved trading of 5,00,000 equity shares of Dharti Proteins Ltd from October 8, 2026 under XT group. This follows an NCLT-approved Resolution Plan under the Insolvency Code. Share capital has been cut from 1,02,77,200 shares to 5,00,000 shares. Of these, 25,000 go to existing public shareholders (5% of new capital), 4,25,000 to the Successful Resolution Applicant, and 50,000 to Secured Financial Creditors. Old promoters are fully wiped out.